in Vitro Susceptibility Testing of Tedizolid Against Isolates of Nocardia

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.01537-17

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Microbiology

Related search

In Vitro Activity of Tedizolid Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

In Vitro Susceptibility Testing and DNA Typing of Saccharomyces Cerevisiae Clinical Isolates.

Journal of Clinical Microbiology
Microbiology
1996English

Susceptibility of 186 Nocardia Sp. Isolates to 20 Antimicrobial Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium Difficile

Frontiers in Microbiology
Microbiology
2018English

In Vitro Activity of Tedizolid Against Gram-Positive Cocci Isolates From Patients Hospitalized With Pneumonia in the United States and Europe, 2014-2016

Journal of Infectious Diseases and Treatment
2018English

In Vitro Activity of Tedizolid and Dalbavancin Against MRSA Strains Is Dependent on Infection Source

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Comparison of Four Antimicrobial Susceptibility Testing Methods to Determine the in Vitro Activities of Piperacillin and Piperacillin-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa

Journal of Clinical Microbiology
Microbiology
2003English

in Vitro Antifungal Susceptibility Testing of Candida Isolates With the EUCAST Methodology, a New Method for ECOFF Determination

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

In Vitro and Intracellular Activity of Imipenem Combined With Tedizolid, Rifabutin, and Avibactam Against Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy